Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Gynecologic Oncology

RSS  

Articles

  • SERMs: Where Are We in 2014?

    Selective estrogen receptor modulators (SERMs) like tamoxifene and raloxifene are now well-established therapeutics, and new agents such as bazedoxifene and ospemifene have recently been introduced. These new agents have unique tissue-specific profiles that allow for a customization of therapeutic effect. In this review, the profiles of bazedoxifene and ospemifene will be compared and discussed relevant to their place in clinical practice.
  • Obesity and LGA

    The findings in a recent study in which investigators evaluated the relative contributions of pre-pregnant weight, weight gain in pregnancy, and the presence of gestational diabetes on the rate of large-for-gestational age fetuses has shed light on how this true complication of pregnancy can be diminished.
  • Genital Hair Removal: What Should We Be Advising Our Patients?

    In this cross-sectional survey of 333 women, the majority reported current pubic hair removal (87%), and two-thirds reported removing all their pubic hair. Most women (60%) had experienced at least one complication because of the removal, the most common complications being epidermal abrasions and ingrown hairs.
  • What Do Fibromyalgia, Pelvic Organ Prolapse Symptoms, and Levator Ani Myalgia Have to Do with Each Other?

    Levator myalgia is a prevalent condition in women presenting with pelvic floor symptoms and is associated with greater symptom bother. Fibromyalgia is associated with an increased risk of levator ani myalgia in women presenting with prolapse.
  • Reproductive health forecast: Look for more options for women

    The need for new contraception options is clear. In the United States, about half of the some 3.4 million pregnancies each year are unintended.
  • Drug interactions and the Pill: Clincians need to check the facts

    To evaluate possible drug-drug interactions with combined pills, clinicians need to understand how the estrogen and progestin in pills are absorbed, distributed, metabolized, and eliminated.
  • New STD guidance on way: Be prepared

    Publication of the newly updated Sexually Transmitted Diseases Treatment Guidelines from the Centers for Disease Control and Prevention is on its way. The proposed new guidance, which replaces information published in 2010, will provide the latest evidence-based treatment recommendations.
  • Quality Family Planning - Put it into practice

    “Providing Quality Family Planning Services — Recommendations of CDC and the U.S. Office of Population Affairs” is the newest member in the “suite” of family planning recommendations from the Centers for Disease Control and Prevention.
  • Family planning issues might be in this Congress' crosshairs

    In the wake of the 2014 midterm elections, Congress has shifted decidedly to the political right. When the 114th Congress convenes in January 2015, Republicans will have their largest majority in the House of Representatives since World War II and will control the Senate for the first time since 2007.
  • Removing financial barriers impacts teen pregnancy, abortion rates

    Teens who received free contraception and were educated about the benefits and disadvantages of various birth control methods in the Contraceptive CHOICE Project in St. Louis were dramatically less likely to get pregnant, give birth, or obtain an abortion compared with other sexually active teens, data suggests in a just-released study.